The following section provides information on Incyte Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Incyte Corp's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Herve Hoppenot

Chairman; Chief Executive Officer; President Executive Board Since: 2014 Age: 62

Mr. Herve Hoppenot has been the Chairman, the President and Chief Executive Officer since 2014. Prior to this, he served as the President; Chief Commercial Officer; Head of Global Product Strategy & Scientific Development; and Senior Vice President, Head of Global Marketing of Novartis Oncology. Initially he worked with Rhone Poulenc, later known as Aventis, in several senior roles of increasing responsibility, including Vice President of Oncology and head of the US Oncology business unit.

Read Hide full bio of Herve Hoppenot

Christiana Stamoulis

Chief Financial Officer; Executive Vice President Senior Management Since: 2019 Age: 51

Ms.Christiana Stamoulis has been the Executive Vice President and Chief Financial Officer of the company since January, 2019. Prior to this, she served as the President and Chief Financial Officer for Unum Therapeutics. Prior to joining Unum, Ms. Stamoulis was the Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals. Before that, she served for 15 years in the investment banking and management consulting sector. She served as a Managing Director at Citigroup’s Investment Banking division and prior to that Ms Stamoulis served as a Senior Investment Banker in the Healthcare Investment Banking Group at Goldman Sachs. She began her career as a strategy consultant at The Boston Consulting Group.

Read Hide full bio of Christiana Stamoulis

Steven H. Stein, M.D.

Executive Vice President; Chief Medical Officer Senior Management Since: 2015 Age: 55

Dr. Steven H. Stein has been the Executive Vice President and Chief Medical Officer of the company since May 2016. He joined Incyte as the Senior Vice President and Chief Medical Officer in March 2015. Prior to this position, he served as Senior Vice President, US Clinical Development & Medical Affairs at Novartis Oncology US. Previously he worked at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and Head of Medicines Development for Hematology and Supportive Care.

Read Hide full bio of Steven H. Stein, M.D.

Dashyant Dhanak, Ph.D.

Executive Vice President; Chief Scientific Officer Senior Management Since: 2018 Age: 61

Dr. Dashyant Dhanak has been the Executive Vice President and Chief Scientific Officer of Incyte since November 2018. Prior to this, he served as vice president and head of Discovery Sciences of Janssen research & Development. Before that, he served for 25 years at GlaxoSmithKline in several leadership roles including vice president and head of the Cancer Epigenetics Discovery performance unit.

Read Hide full bio of Dashyant Dhanak, Ph.D.

Michael Morrissey

Head - Global Technical Operations; Executive Vice President Senior Management Since: 2016 Age: 58
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer